A. Chéret

Most-cited papers

1. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

   J. Molina, C. Capitant, B. Spire, G. Pialoux +32 more

   2015New England Journal of Medicine1,445 citations Open access

   Semantic Scholar

   Save

2. Brief Report

   D. Wohl, S. Oka, N. Clumeck, A. Clarke +15 more

   2024International Conference on Numerical Simulation of Optoelectronic Devices1,291 citations Open access

   Semantic Scholar

   Save

3. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.

   J. Molina, I. Charreau, C. Chidiac, G. Pialoux +107 more

   2017Lancet. Infectious Diseases (Print)344 citations Open access

   Semantic Scholar

   Save

4. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.

   F. Boué, J. Gabarre, C. Gisselbrecht, J. Reynés +6 more

   2006Journal of Clinical Oncology200 citations Open access

   Semantic Scholar

   Save

5. Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications

   V. Avettand-Fenoël, L. Hocqueloux, J. Ghosn, A. Chéret +4 more

   2016Clinical Microbiology Reviews189 citations Open access

   Semantic Scholar

   Save

6. Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.

   A. Chéret, C. Bacchus-Souffan, V. Avettand-Fenoël, A. Mélard +13 more

   2015Journal of Antimicrobial Chemotherapy108 citations Open access

   Semantic Scholar

   Save

7. Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study.

   M. Valantin, Sidonie Lambert-Niclot, P. Flandre, L. Morand-Joubert +24 more

   2012Journal of Antimicrobial Chemotherapy76 citations

   Semantic Scholar

   Save

8. COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

   Sheryl Ann Ryuzo Laurent Lara Andrew Shingo Elisabeth Dia Abdukahil Abe Abel Absil Acker Adachi Adam Adrião , S. Abdukahil, Ryuzo Abe, Laurent Abel +496 more

   2021Infection75 citations Open access

   Semantic Scholar

   Save

9. A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection

   C. Bacchus, A. Chéret, V. Avettand-Fenoël, Georges Nembot +16 more

   2013PLoS ONE73 citations Open access

   Semantic Scholar

   Save

10. Impact of Human Immunodeficiency Virus Type 1 Subtype on First-Line Antiretroviral Therapy Effectiveness

    L. Bocket, A. Chéret, S. Deuffic-Burban, P. Choisy +8 more

    2005Antiviral Therapy73 citations Open access

    Semantic Scholar

    Save

11. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.

    Guillemette Antoni, C. Tremblay, C. Delaugerre, I. Charreau +55 more

    2019The Lancet HIV69 citations Open access

    Semantic Scholar

    Save

12. Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.

    A. Chéret, Georges Nembot, A. Mélard, C. Lascoux +19 more

    2015Lancet. Infectious Diseases (Print)69 citations

    Semantic Scholar

    Save

13. Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV

    P. Pradat, T. Huleux, F. Raffi, P. Delobel +14 more

    2018AIDS (London)56 citations

    Semantic Scholar

    Save

14. NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147

    F. Gondois-Rey, A. Chéret, S. Granjeaud, F. Mallet +11 more

    2017Clinical & Translational Immunology56 citations Open access

    Semantic Scholar

    Save

15. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial.

    P. Mercié, Julie Arsandaux, C. Katlama, S. Ferret +69 more

    2018The Lancet HIV53 citations

    Semantic Scholar

    Save

16. Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study

    L. Cotte, T. Ferry, P. Puglièse, M. Valantin +9 more

    2017PLoS ONE53 citations Open access

    Semantic Scholar

    Save

17. Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

    L. Cuzin, P. Pugliese, Christine Katlama, F. Bani-Sadr +268 more

    2018Journal of Antimicrobial Chemotherapy51 citations

    Semantic Scholar

    Save

18. Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers

    A. Makinson, S. Eymard-Duvernay, F. Raffi, S. Abgrall +11 more

    2016AIDS (London)47 citations Open access

    Semantic Scholar

    Save

19. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.

    P. Frange, L. Assoumou, D. Descamps, A. Chéret +15 more

    2015Journal of Antimicrobial Chemotherapy46 citations Open access

    Semantic Scholar

    Save

20. Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients

    I. Poizot-Martin, A. Naqvi, V. Obry-Roguet, M. Valantin +9 more

    2015PLoS ONE37 citations Open access

    Semantic Scholar

    Save

21. The value of open-source clinical science in pandemic response: lessons from ISARIC

    Ali Sheryl Ann Nurul Najmee Ryuzo Laurent Lara Subhash Abbas Abdukahil Abdulkadir Abe Abel Absil Acharya , A. Abbas, S. Abdukahil, Nurul Najmee Abdulkadir +496 more

    2021Lancet. Infectious Diseases (Print)34 citations Open access

    Semantic Scholar

    Save

22. Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study.

    A. Ursenbach, Vincent Max, M. Maurel, F. Bani-Sadr +297 more

    2020Journal of Antimicrobial Chemotherapy33 citations

    Semantic Scholar

    Save

23. Spectrum and Incidence Trends of AIDS- and Non–AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort

    I. Poizot-Martin, C. Lions, C. Allavena, T. Huleux +17 more

    2020Cancer Epidemiology, Biomarkers and Prevention33 citations

    Semantic Scholar

    Save

24. CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART

    I. Poizot-Martin, C. Allavena, C. Duvivier, C. E. Cano +6 more

    2016PLoS ONE33 citations Open access

    Semantic Scholar

    Save

25. Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

    V. Virlogeux, F. Zoulim, P. Puglièse, I. Poizot-Martin +15 more

    2017BMC Medicine32 citations Open access

    Semantic Scholar

    Save

26. Impact of early cART on HIV blood and semen compartments at the time of primary infection

    A. Chéret, C. Durier, A. Mélard, M. Ploquin +10 more

    2017PLoS ONE32 citations Open access

    Semantic Scholar

    Save

27. A Mature NK Profile at the Time of HIV Primary Infection Is Associated with an Early Response to cART

    F. Gondois-Rey, A. Chéret, F. Mallet, Ghislain Bidaut +11 more

    2017Frontiers in Immunology28 citations Open access

    Semantic Scholar

    Save

28. Ageing with HIV: do comorbidities and polymedication drive treatment optimization?

    L. Cuzin, C. Katlama, L. Cotte, P. Pugliese +7 more

    2017HIV Medicine27 citations Open access

    Semantic Scholar

    Save

29. Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection

    P. Gantner, L. Cotte, C. Allavena, F. Bani-Sadr +10 more

    2019PLoS ONE26 citations Open access

    Semantic Scholar

    Save

30. CD8 T-Cells from Most HIV-Infected Patients Lack Ex Vivo HIV-Suppressive Capacity during Acute and Early Infection

    C. Lécuroux, I. Girault, A. Chéret, P. Versmisse +6 more

    2013PLoS ONE25 citations Open access

    Semantic Scholar

    Save

31. HIV and hypogonadism: a new challenge for young-aged and middle-aged men on effective antiretroviral therapy

    M. Lachâtre, A. Pasquet, F. Ajana, B. Soudan +6 more

    2016AIDS (London)24 citations

    Semantic Scholar

    Save

32. HIV is associated with airway obstruction: a matched controlled study

    A. Makinson, M. Hayot, S. Eymard-Duvernay, C. Ribet +15 more

    2017AIDS (London)23 citations Open access

    Semantic Scholar

    Save

33. Is Total Community Viral Load a Robust Predictive Marker of the Efficacy of the TasP Strategy?

    S. Hénard, E. Jeanmaire, Y. Nguyen, Y. Yazdanpanah +7 more

    2012Journal of Acquired Immune Deficiency Syndromes22 citations Open access

    Semantic Scholar

    Save

34. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors

    Arnoo Shaiykova, A. Pasquet, C. Goujard, G. Lion +12 more

    2018AIDS (London)21 citations

    Semantic Scholar

    Save

35. Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort

    S. Lang, J. Lacombe, M. Mary-Krause, M. Partisani +11 more

    2015PLoS ONE19 citations Open access

    Semantic Scholar

    Save

36. Dolutegravir Cerebrospinal Fluid Diffusion in HIV-1–Infected Patients with Central Nervous System Impairment

    Thibaut Gelé, V. Furlan, A. Taburet, C. Pallier +5 more

    2019Open Forum Infectious Diseases18 citations Open access

    Semantic Scholar

    Save

37. Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status

    A. Baldé, S. Lang, A. Wagner, J. Ferrières +13 more

    2019PLoS ONE18 citations Open access

    Semantic Scholar

    Save

38. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?

    P. Pradat, P. Puglièse, I. Poizot-Martin, M. Valantin +207 more

    2017Journal of Infection18 citations

    Semantic Scholar

    Save

39. A genetic fingerprint associated with durable HIV remission after interruption of antiretroviral treatment. ANRS VISCONTI/PRIMO

    A. Essat, Anaïs Chapel, K. Amokrane, V. Monceaux +17 more

    2025i Medicina17 citations Open access

    Semantic Scholar

    Save

40. Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France

    Sylvie Brégigeon-Ronot, A. Chéret, A. Cabié, T. Prazuck +6 more

    2017Patient Preference and Adherence17 citations Open access

    Semantic Scholar

    Save

41. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

    S. Raymond, F. Nicot, C. Pallier, Pantxika Bellecave +171 more

    2018Clinical Infectious Diseases16 citations Open access

    Semantic Scholar

    Save

42. Motivational interviewing training for medical students: A pilot pre-post feasibility study.

    A. Chéret, C. Durier, Nicolas Noël, K. Bourdic +6 more

    2018Patient Education and Counseling16 citations

    Semantic Scholar

    Save

43. Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results

    D. Wohl, S. Oka, N. Clumeck, A. Clarke +15 more

    2016Journal of Acquired Immune Deficiency Syndromes16 citations Open access

    Semantic Scholar

    Save

44. Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection

    K. Stéfic, Sophie Novelli, N. Mahjoub, R. Seng +23 more

    2018Journal of Infectious Diseases15 citations

    Semantic Scholar

    Save

45. Multimorbidity in Elderly Subjects according to the year of diagnosis of HIV-Infection - A Cross-Sectional DATAIDS Cohort Study.

    M. Demontès, Sabrina Eymard Duvernay, C. Allavena, T. Jovelin +23 more

    2019Clinical Infectious Diseases14 citations Open access

    Semantic Scholar

    Save

46. Hepatitis C treatment initiation in HIV-HCV coinfected patients

    L. Cotte, P. Puglièse, M. Valantin, L. Cuzin +7 more

    2016BMC Infectious Diseases14 citations Open access

    Semantic Scholar

    Save

47. Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection.

    R. Veil, I. Poizot-Martin, J. Reynés, C. Goujard +11 more

    2019AIDS (London)13 citations Open access

    Semantic Scholar

    Save

48. Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort.

    A. Le Guillou, P. Puglièse, François Raffi, A. Cabié +245 more

    2019Clinical Infectious Diseases13 citations

    Semantic Scholar

    Save

49. Rectal Cell-Associated HIV-1 RNA: A New Marker Ready for the Clinic

    A. Lafeuillade, A. Chéret, G. Hittinger, D. Bernardini +3 more

    2009HIV Clinical Trials13 citations Open access

    Semantic Scholar

    Save

50. Weight gain following the single substitution of tenofovir disoproxil fumarate by tenofovir alafenamide in HIV‐infected people from the French Dat'AIDS cohort: A propensity score‐matched analysis

    L. Hocqueloux, A. Ménard, C. Arvieux, V. Joly +6 more

    2023HIV Medicine12 citations Open access

    Semantic Scholar

    Save